Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Vulvar Neoplasms × cemiplimab × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 41 Melanoma 19 Squamous Cell Carcinoma of Head and Neck 15 Neoplasm Metastasis 15 Neoplasms 14 Skin Neoplasms 11 Lung Neoplasms 10 Recurrence 8 Head and Neck Neoplasms 8 Carcinoma, Squamous Cell 8 Carcinoma, Renal Cell 8 Colorectal Neoplasms 7 Urinary Bladder Neoplasms 6 Ovarian Neoplasms 6 Breast Neoplasms 6 Adenocarcinoma 6 Triple Negative Breast Neoplasms 5 Prostatic Neoplasms 5 Carcinoma, Merkel Cell 5 Carcinoma 5 Pancreatic Neoplasms 4 Multiple Myeloma 4 Glioblastoma 4 Colonic Neoplasms 4 Uterine Cervical Neoplasms 3 Stomach Neoplasms 3 Mycosis Fungoides 3 Fallopian Tube Neoplasms 3 Endometrial Neoplasms 3 Cutaneous Squamous Cell Carcinoma 3

Interventions

Radiotherapy 8 Cisplatin 8 Methods 6 pembrolizumab 5 Papillomavirus Vaccines 4 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 4 Early Intervention, Educational 4 fludarabine 3 Vaccines, Synthetic 3 Vaccines 3 Radiosurgery 3 Radiation 3 Platinum 3 Palliative Care 3 Nivolumab 3 Gemcitabine 3 Cyclophosphamide 3 Carboplatin 3 Brachytherapy 3 Bleomycin 3 1,2-diaminocyclohexaneplatinum II citrate 3 tremelimumab 2 lenvatinib 2 entinostat 2 durvalumab 2 aldesleukin 2 aflibercept 2 Trastuzumab 2 Specimen Handling 2 Sentinel Lymph Node Biopsy 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07101848 2025-08-03

BRAVA VULVAR

Hospital Israelita Albert Einstein

Phase 2 Not yet recruiting

Vulvar Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡